Biophysical differences between chronic myelogenous leukemic quiescent and proliferating stem/progenitor cells. Academic Article uri icon

Overview

abstract

  • The treatment of chronic myeloid leukemia (CML), a clonal myeloproliferative disorder has improved recently, but most patients have not yet been cured. Some patients develop resistance to the available tyrosine kinase treatments. Persistence of residual quiescent CML stem cells (LSCs) that later resume proliferation is another common cause of recurrence or relapse of CML. Eradication of quiescent LSCs is a promising approach to prevent recurrence of CML. Here we report on new biophysical differences between quiescent and proliferating CD34+ LSCs, and speculate how this information could be of use to eradicate quiescent LSCs. Using AFM measurements on cells collected from four untreated CML patients, substantial differences are observed between quiescent and proliferating cells in the elastic modulus, pericellular brush length and its grafting density at the single cell level. The higher pericellular brush densities of quiescent LSCs are common for all samples. The significance of these observations is discussed.

publication date

  • July 16, 2016

Research

keywords

  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Neoplastic Stem Cells

Identity

PubMed Central ID

  • PMC5116407

Scopus Document Identifier

  • 84984636149

Digital Object Identifier (DOI)

  • 10.1016/j.nano.2016.06.016

PubMed ID

  • 27431055

Additional Document Info

volume

  • 12

issue

  • 8